Recall: D-0505-2026

Class II - Potentially Harmful

Class IIClassification

2026-04-01Initiated

OngoingStatus

Wells Pharma of Houston LLCFirm

Product

fentaNYL Citrate Injectable Solution, Narcotic, CII, 1250 mcg/25mL (50 mcg per mL), 25 mL, wells pharma of Houston, NDC 73702-204-25.

Reason

cGMP deviations.

Distribution

U.S. Nationwide.

Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.